PP
SZYM

PDT Partners’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

PDT Partners’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-58,665
Closed -$632K – 1416
2013
Q3 		$632K Buy
+58,665
New +$668K 0.02% 959

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PDT Partners's SZYM Position: Q4 2013 in Review

PDT Partners sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q4 2013, closing a stake of 58,665 shares — an estimated $632K sold.

PDT Partners first reported a position in SZYM in Q3 2013 and held it in 1 quarter. The position peaked at $632K in Q3 2013. 105 funds tracked by Wall St. Rank hold SZYM as of Q4 2013.

  • PDT Partners reported no remaining SOLAZYME INC COM STK (DE) position as of Q4 2013 after selling out during the quarter.
  • PDT Partners sold 58,665 SOLAZYME INC COM STK (DE) shares in Q4 2013, an estimated $632K.
  • PDT Partners first reported a position in SOLAZYME INC COM STK (DE) in Q3 2013 and held it in 1 quarter.
  • PDT Partners's SOLAZYME INC COM STK (DE) position peaked at $632K in Q3 2013.
  • 105 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q4 2013.

Based on PDT Partners's 13F filing for Q4 2013, filed 14 Feb 2014.